Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CANB

Can B (CANB) Stock Price, News & Analysis

Can B logo

About Can B Stock (NASDAQ:CANB)

Key Stats

Today's Range
$0.0159
$0.0159
50-Day Range
$0.37
$8.24
52-Week Range
$0.27
$1.05
Volume
4 shs
Average Volume
189,959 shs
Market Capitalization
$1.33 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CANB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Can B and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CANB Stock News Headlines

SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of the profits are typically already gone. SpaceX insiders bought in at a $20 billion valuation - you're being offered entry at $1.75 trillion. But one small, publicly traded company sits directly in SpaceX's supply chain, still priced like Wall Street hasn't noticed. It powers critical infrastructure Musk's operation can't run without. Dylan Jovine is naming it today, free.tc pixel
See More Headlines

CANB Stock Analysis - Frequently Asked Questions

Can B (CANB) raised $10 million in an IPO on Tuesday, August 9th 2022. The company issued 2,000,000 shares at a price of $5.05 per share. H.C. Wainwright & Co. served as the underwriter for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Can B investors own include Fulcrum Therapeutics (FULC), Actinium Pharmaceuticals (ATNM), Chimerix (CMRX), Heatwurx (PCSA).

Company Calendar

Today
6/13/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Drugs, proprietaries, & sundries
Sub-Industry
N/A
Current Symbol
NASDAQ:CANB
CIK
1509957
Fax
N/A
Employees
16
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$9.74 million
Net Margins
-1,238.33%
Pretax Margin
-1,351.68%
Return on Equity
N/A
Return on Assets
-218.65%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.14
Quick Ratio
0.12

Sales & Book Value

Annual Sales
$2.16 million
Price / Sales
0.62
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.28) per share
Price / Book
-0.06

Miscellaneous

Outstanding Shares
83,670,000
Free Float
74,137,000
Market Cap
$1.33 million
Optionable
Not Optionable
Beta
1.46
10 Stocks Set to Soar in 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:CANB) was last updated on 6/13/2026 by MarketBeat.com Staff.
From Our Partners